• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用适应性cDNA可变区盒式结构实现嵌合抗体的高水平表达。

High-level expression of chimeric antibodies using adapted cDNA variable region cassettes.

作者信息

Gillies S D, Lo K M, Wesolowski J

机构信息

Damon Biotech, Inc., Needham Heights, MA 02194.

出版信息

J Immunol Methods. 1989 Dec 20;125(1-2):191-202. doi: 10.1016/0022-1759(89)90093-8.

DOI:10.1016/0022-1759(89)90093-8
PMID:2514231
Abstract

A rapid and generally applicable method for the modification of immunoglobulin cDNAs was developed so that the variable (V) regions could be expressed as cassettes, together with a variety of constant regions. Murine cDNAs were isolated, sequenced and the V regions joined to short oligonucleotides providing both splice donor sites and unique restriction sites for insertion into an expression vector. Using this strategy we have expressed the V regions of several murine antibodies, together with the human gamma 1 constant region. Although most of these chimeric antibodies were readily expressed, one murine light-chain cDNA sequence could not be expressed in transfected hybridoma cells. Reconstruction experiments indicate that the sequence created by the fusion of the murine leader and variable region blocked expression at the level of RNA accumulation. The methods described, as well as the potential problems of expression, are applicable to both traditional cDNA fragments and those obtained by in vitro amplification techniques.

摘要

我们开发了一种快速且普遍适用的方法来修饰免疫球蛋白cDNA,以便可变(V)区能够作为盒式结构与多种恒定区一起表达。分离并测序了鼠源cDNA,将V区与短寡核苷酸连接,这些寡核苷酸提供了剪接供体位点和用于插入表达载体的独特限制性位点。利用这一策略,我们表达了几种鼠源抗体的V区以及人γ1恒定区。尽管大多数这些嵌合抗体很容易表达,但一个鼠源轻链cDNA序列在转染的杂交瘤细胞中无法表达。重建实验表明,由鼠源前导肽和可变区融合产生的序列在RNA积累水平上阻断了表达。所描述的方法以及表达中可能出现的问题,适用于传统的cDNA片段以及通过体外扩增技术获得的片段。

相似文献

1
High-level expression of chimeric antibodies using adapted cDNA variable region cassettes.使用适应性cDNA可变区盒式结构实现嵌合抗体的高水平表达。
J Immunol Methods. 1989 Dec 20;125(1-2):191-202. doi: 10.1016/0022-1759(89)90093-8.
2
Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.基因突变和替代性RNA剪接导致人类γ重链病中截短的Ig轻链。
J Immunol. 1988 Sep 1;141(5):1738-44.
3
Cloning, expression and characterization of a murine-human chimeric antibody with specificity for pre-S2 surface antigen of hepatitis B virus.一种对乙型肝炎病毒前S2表面抗原具有特异性的鼠-人嵌合抗体的克隆、表达及特性分析
Mol Immunol. 1993 Dec;30(18):1647-54. doi: 10.1016/0161-5890(93)90438-h.
4
Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.编码抗体BrE-3可变区的cDNA克隆及嵌合抗体的构建。
Hybridoma. 1993 Feb;12(1):15-23. doi: 10.1089/hyb.1993.12.15.
5
Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.编码抗体KC4G3可变区的cDNA克隆及嵌合抗体的构建。
Hybridoma. 1993 Aug;12(4):485-9. doi: 10.1089/hyb.1993.12.485.
6
Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.小鼠/人嵌合Me1-14抗体:可变区基因的基因组克隆、与人类恒定区基因的连接、表达及特性分析
Hybridoma. 1994 Apr;13(2):87-97. doi: 10.1089/hyb.1994.13.87.
7
Cloning and sequence analysis of kappa and gamma cynomolgus monkey immunoglobulin cDNAs.食蟹猴κ和γ免疫球蛋白cDNA的克隆与序列分析。
Dev Comp Immunol. 1993 Nov-Dec;17(6):549-60. doi: 10.1016/s0145-305x(05)80010-2.
8
Nucleotide sequences of immunoglobulin heavy and light chain V-regions from a monoclonal autoantibody specific for a unique set of small nuclear ribonucleoprotein complexes.针对一组独特的小核核糖核蛋白复合体的单克隆自身抗体的免疫球蛋白重链和轻链V区的核苷酸序列。
Nucleic Acids Res. 1992 Aug 11;20(15):4099. doi: 10.1093/nar/20.15.4099.
9
Sequences of cDNAs encoding immunoglobulin heavy- and light-chain variable regions from two anti-dioxin monoclonal antibodies.来自两种抗二噁英单克隆抗体的编码免疫球蛋白重链和轻链可变区的cDNA序列。
Gene. 1994 Nov 18;149(2):385-6. doi: 10.1016/0378-1119(94)90185-6.
10
Characterization of an immunoglobin cDNA clone containing the variable and constant regions for the MOPC 21 kappa light chain.一个包含MOPC 21 κ轻链可变区和恒定区的免疫球蛋白cDNA克隆的鉴定
Nucleic Acids Res. 1978 Sep;5(9):3101-11. doi: 10.1093/nar/5.9.3101.

引用本文的文献

1
A clinical observational study of dinutuximab beta as first-line maintenance treatment for patients with high-risk neuroblastoma in China.在中国进行的一项关于地努图希单抗β作为高危神经母细胞瘤患者一线维持治疗的临床观察研究。
BMC Pediatr. 2025 Mar 17;25(1):203. doi: 10.1186/s12887-025-05568-x.
2
Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors.使用Jurkat报告T细胞系评估新型嵌合抗原受体的功能。
Front Mol Med. 2023 Feb 22;3:1070384. doi: 10.3389/fmmed.2023.1070384. eCollection 2023.
3
GD2-targeting therapy: a comparative analysis of approaches and promising directions.
靶向 GD2 的治疗方法:方法比较分析及有前景的方向。
Front Immunol. 2024 Mar 15;15:1371345. doi: 10.3389/fimmu.2024.1371345. eCollection 2024.
4
Safety and efficacy of dinutuximab in the treatment of neuroblastoma: A review.地努图希单抗治疗神经母细胞瘤的安全性与有效性:一项综述
J Res Med Sci. 2023 Sep 29;28:71. doi: 10.4103/jrms.jrms_727_22. eCollection 2023.
5
Biology of GD2 ganglioside: implications for cancer immunotherapy.GD2神经节苷脂生物学:对癌症免疫治疗的启示
Front Pharmacol. 2023 Aug 21;14:1249929. doi: 10.3389/fphar.2023.1249929. eCollection 2023.
6
The human antibody sequence space and structural design of the V, J regions, and CDRH3 with Rosetta.利用 Rosetta 研究人类抗体序列空间和 V、J 区以及 CDRH3 的结构设计。
MAbs. 2022 Jan-Dec;14(1):2068212. doi: 10.1080/19420862.2022.2068212.
7
Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy.肿瘤相关糖链作为免疫治疗的靶点:威斯塔研究所的经验/传承。
Monoclon Antib Immunodiagn Immunother. 2021 Jun;40(3):89-100. doi: 10.1089/mab.2021.0024.
8
Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.儿童癌症免疫治疗靶点的研究进展:聚焦于磷脂酰聚糖-2 和 B7-H3。
Pharmacol Ther. 2021 Jul;223:107892. doi: 10.1016/j.pharmthera.2021.107892. Epub 2021 May 14.
9
GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells.靶向GD2的嵌合抗原受体T细胞通过清除乳腺癌干细胞样细胞来预防转移灶形成。
Oncoimmunology. 2019 Nov 7;9(1):1683345. doi: 10.1080/2162402X.2019.1683345. eCollection 2020.
10
Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy.肿瘤相关碳水化合物抗原嵌合抗原受体 T 细胞和双特异性抗体在抗肿瘤免疫治疗中的最新进展。
Semin Immunol. 2020 Feb;47:101390. doi: 10.1016/j.smim.2020.101390. Epub 2020 Jan 22.